Back to Nephrology
Nephrologyv2014Evidence-Based

CKD Prediction in HIV+ Patients

Determines likelihood of HIV patients developing CKD in the next 5 years, whether they take tenofovir or not

Clinical Input Parameters

years
mg/dL
mmHg
mg/dL
cells/µL
Clinical Assessment
Awaiting Parameters
ckd risk percentage
—percent
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CKD Prediction in HIV+ Patients is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within nephrology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of risk factor points: Age (0-6) + Glucose >140 (2) + SBP >140 (1) + Hypertension (2) + Triglycerides >200 (1) + Proteinuria (2) + CD4+ <200 (1). 5-year CKD risk based on total score and tenofovir use status.

Clinical Pearls & Practice Notes

  • Based on prospective cohort study of HIV-positive male veterans
  • Helps guide clinical decision-making around tenofovir use
  • Traditional kidney risk factors are dominant contributors
  • CD4+ count included but HIV RNA viral load is not a component
  • Number needed to harm (NNH) for tenofovir decreases with higher scores
  • Should be used in conjunction with clinical judgment
  • Regular monitoring of kidney function recommended regardless of risk score

Evidence & Literature Citations

  1. Scherzer R, Gandhi M, Estrella MM, Tien PC, Deeks SG, Grunfeld C, Peralta CA, Shlipak MG. A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS. 2014;28(9):1289-95.
  2. Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D Study Group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809.

Score Interpretation Ranges

Low Risk0 – 5 pts

Low risk for CKD development

Moderate Risk5 – 15 pts

Moderate risk for CKD development

High Risk15 – 100 pts

High risk for CKD development

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.